SCHEMBL310507

SCHEMBL310507

CC(C)(CO)NC(C)(C)CO

nearest known ligand 0.39

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.31
NPSR1 Q6W5P4 1/20 0.30
POLB P06746 1/20 0.30
ATM Q13315 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7807867 0.86
SCHEMBL19353758 0.83 ALDH1A1 (0.40)
SCHEMBL17320126 0.79
SCHEMBL17320130 0.77
SCHEMBL9734813 0.76
SCHEMBL10825838 0.74
SCHEMBL6285315 0.74 KDM4C (0.38)
SCHEMBL419777 0.74
SCHEMBL5985259 0.74
SCHEMBL10473936 0.73 CA4 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025098878-A1 DEGRADABLE POLYMERS, AS WELL AS METHODS FOR MAKINGS AND DEGRADING SAME AND USES THEREOF FACHHOCHSCHULE NORDWESTSCHWEIZ (CH) 2025-05-15 WO claimed
WO-2025098878-A1 DEGRADABLE POLYMERS, AS WELL AS METHODS FOR MAKINGS AND DEGRADING SAME AND USES THEREOF FACHHOCHSCHULE NORDWESTSCHWEIZ (CH) 2025-05-15 WO disclosed
EP-2620429-A1 Hydroxylamine compounds and methods of their use Colby Pharmaceutical Company (US) 2013-07-31 EP disclosed
US-8093409-B2 Method for producing cyclic unsaturated compound NIPPON SHOKUBAI CO., LTD. (JP) 2012-01-10 US disclosed
US-20100143805-A1 NITROXIDES FOR LITHIUM-ION BATTERIES CIBA CORPORATION (NY) 2010-06-10 US disclosed
US-20100143805-A1 NITROXIDES FOR LITHIUM-ION BATTERIES CIBA CORPORATION (NY) 2010-06-10 US disclosed
US-20090299009-A1 METHOD FOR PRODUCING CYCLIC UNSATURATED COMPOUND NIPPON SHOKUBAI CO., LTD. (JP) 2009-12-03 US disclosed
EP-2061778-A1 METHOD FOR PRODUCING CYCLIC UNSATURATED COMPOUND Nippon Shokubai Co., Ltd. (JP) 2009-05-27 EP disclosed
WO-2008110466-A1 NITROXIDES FOR LITHIUM-ION BATTERIES BASF SE (CH) 2008-09-18 WO disclosed
WO-2008023823-A1 METHOD FOR PRODUCING CYCLIC UNSATURATED COMPOUND NIPPON SHOKUBAI CO., LTD. (JP) 2008-02-28 WO disclosed
US-20030125489-A1 Open chain alkoxyamine compounds and their use as polymerization regulators NESVADBA PETER (CH) 2003-07-03 US disclosed
US-6518326-B1 Open chain alkoxyamine compounds and their use as polymerization regulators CIBA SPECIALTY CHEMICALS CORPORATION 2003-02-11 US disclosed
EP-1100772-A1 OPEN CHAIN ALKOXYAMINE COMPOUNDS AND THEIR USE AS POLYMERIZATION REGULATORS Ciba SC Holding AG (CH) 2001-05-23 EP disclosed
WO-2000007981-A1 OPEN CHAIN ALKOXYAMINE COMPOUNDS AND THEIR USE AS POLYMERIZATION REGULATORS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2000-02-17 WO disclosed
US-5089614-A Polysubstituted 2-morpholones THE B. F. GOODRICH COMPANY (US) 1992-02-18 US disclosed
US-4914232-A FOR POLYMERS THE B. F. GOODRICH COMPANY (US) 1990-04-03 US disclosed
US-4528370-A Polysubstituted 2-morpholones NOVEON IP HOLDINGS CORP., FORMERLY KNOWN AS PMD HOLDINGS CORP. 1985-07-09 US disclosed
US-4256636-A REACTING AN AZO-DI-ISOBUTYRIC ACID IMINOALKYL ETHER WITH A MONOALKANOLAMINE AND A DIALKANOLAMINE, FOAMS BAYER AKTIENGESELLSCHAFT (DE) 1981-03-17 US disclosed
EP-0009659-A1 Process of preparation of aqueous polymer dispersions and their use BAYER AG (DE) 1980-04-16 EP disclosed
EP-0009186-A1 Azo-diisobutyryl-(N,N'-hydroxyalkyl)-amidines, their preparation and their use as polymerisation initiators, as crosslinking agents and as blowing agents BAYER AG (DE) 1980-04-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030125489-A1 Open chain alkoxyamine compounds and their use as polymerization regulators ALOX5, PTGER1, ALOX12 HTT 1179/4885NPSR1 4018/4885POLB 355/4885
US-20100143805-A1 NITROXIDES FOR LITHIUM-ION BATTERIES OGG1, NOX4, NQO1 HTT 2362/4885NPSR1 1630/4885POLB 1097/4885
US-20090299009-A1 METHOD FOR PRODUCING CYCLIC UNSATURATED COMPOUND FASN, SQLE, ALOX5 HTT 4630/4885NPSR1 1728/4885POLB 1401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.